Showing results (521-530 of 556) with videos related to

Sort By:
Pageof 56
Gene|August 26, 1998
Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesteraseK Loughney, T R Hill, V A Florio, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2023
Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewColette J Shen, Stephen F Kry, Jeffrey C Buchsbaum, et al.
The Journal of Clinical Investigation|March 28, 2018
Role of proNGF/p75 signaling in bladder dysfunction after spinal cord injuryJae Cheon Ryu, Katharine Tooke, Susan E Malley, et al.
Radiation Oncology (London, England)|April 2, 2025
Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapyHang Qi, Lei Hu, Sheng Huang, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
JAMA Ophthalmology|May 8, 2025
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA TestChuan Gao, Juber Patel, Melissa Robbins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal MelanomaTyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, et al.
The British Journal of Ophthalmology|May 11, 2021
Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical studyCarley M Bogan, Jessica V Kaczmarek, Janene M Pierce, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2025
Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial ChemotherapyAlexander Ramos, Andrew L A Garton, Jared Knopman, et al.
JAMA Ophthalmology|May 8, 2025
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple MyelomaVivian Lee, Malin Hultcrantz, Stephanie Petrone, et al.
Pageof 56